AstraZeneca

theme of this assessment is Metoprolol succinate. The trade names this drug is known as in New Zealand is Betaloc CR and AFT-Metoprolol CR (AFT-Pharmaceuticals Ltd, 2009); AstraZeneca Limited, 2014). 2. General classification of given drug This drug is an antihypertensive medication and a beta1-selective beta-blocker (AstraZeneca Limited, 2014). 3. Indication of use and purpose of given drug Jack is taking Metoprolol succinate for hypertension. Hypertension is when the patient’s blood pressure…

Cloud computing and software-as-a-service (SaaS) are forms of __________. a) in-house development b) offshoring c) outsourcing d) sourcing 4. Why did British-Swedish company AstraZeneca undergo a major restructure from a traditional model to a loosely-coupled business model? a) Management forecasted a significant loss in its sales revenues. b) Management wanted to implement the latest IT and social networks. c) Competition in…

The development of Zurampic®(Lesinurad), a first selective uric acid resorption inhibitor to treat gout Summary: Gout is the most common inflammatory arthropathy in the western world, which is caused by the excess accumulation of uric acid in the blood instead of normally excreting by kidney. Millions of people suffer from this kind of arthritis with an attack of sudden burning pain, stiffness, and swelling in a joint(usually a big toe). However, the current treatment for gout is far from…

or substandard care” (Kenney, P. 7). After reporting his findings on a being fired for not keeping silent he proceeded to file a First Amendment case against the state and multiple suits against Southwood Psychiatric Hospital, Pfizer Inc., and AstraZeneca. In all cases he was successful with the help of…

1. The Challenge AstraZeneca developed a breakthrough technology that would revolutionize inhaled medication delivery for sufferers of COPD, and needed to find a creative territory that the Patient group found compelling The research sought to understand how five different creative ideas performed from a variety of dimensions including: clarity of main idea, emotional relevance to a COPD Patient, and differentiation from other mediations on the market The research was also designed to optimize…

Januvia and Janumet are two of Merck & Co.'s (MRK) blockbuster drugs in its diabetes franchise. They're used to lower blood sugar levels in patients with type 2 diabetes. The combined sales for these drugs were ~$1.3 billion for 1Q17, a ~5.0% fall from $1.4 billion in 1Q16. Chart - 006 - JJ Uses for Januvia and Janumet Januvia and Janumet, its combination version, are drugs classified as DPP-4 inhibitors. DPP-4 is the enzyme dipeptidyl peptidase-4, which removes incretin from the human body…

Some PAPs are much easier to use than others. Therefore, the PAPs most reported to be used were Pfizer, Bristol-Myers Squibb, Merck, GlaxoSmithKline, AstraZeneca, Wyeth-Ayerst, Parke-Davis, Eli Lilly, and GlaxoWellcome (Duke, Raube, & Lipton, 2005, p. 729-730). 3. What are the requirements for Patient Assistance Program? “Most companies require some kind of income proof like a W2 or 1040. If they are…

Solution for Antibiotic Resistance So knowing the history about the discovery of antibiotics and what was the main purpose of this drug will put your mind at ease. Like I stated earlier, our society take antibiotics for any reason. One of the best solution is to take a broader view of the microbes. Microbes which are single-cell organisms so tiny that millions can fit into the eye of a needle. They are the oldest form of life on earth. Microbe is a term for tiny creatures that…

Pfizer Inc. (NYSE: PFE) and Allergan PLC (NYSE: AGN) has declared that their boards of directors have collectively approved, and the companies have entered into, a definitive merger agreement under which Pfizer, a global developing biopharmaceutical company, will combine with Allergan, a global pharmaceutical company and a leader in a recent industry model – Growth Pharma, in a stock transaction currently valued at $363.63 per Allergan share, for a total enterprise value of approximately $160…

created at a slowing rate, which could mean trouble for those who become infected with superbugs. In the article “Meeting the Societal Need for New Antibiotics: the Challenges for the Pharmaceutical Industry“ Seamus O’Brien (2015), an employee of AstraZeneca, one of the world’s largest pharmaceutical corporations, stated “There are significant challenges for the pharmaceutical industry to discover and develop new antibiotics including a business model that balances reasonable reimbursement with…